- Home
- EQH vs SLRX Comparison
EQH vs SLRX Comparison
Compare EQH & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQH | SLRX |
|---|---|---|
| Founded | 1859 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 3.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EQH | SLRX |
|---|---|---|
| Price | $48.03 | $0.69 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $64.33 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 388.9K |
| Earning Date | 02-04-2026 | 11-14-2025 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,224,000,000.00 | N/A |
| Revenue This Year | $25.11 | N/A |
| Revenue Next Year | $5.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.38 | N/A |
| 52 Week Low | $41.39 | $0.64 |
| 52 Week High | $56.61 | $108.00 |
Technical Indicators
Market Signals| Indicator | EQH | SLRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.91 | 26.08 |
| Support Level | $47.40 | $0.64 |
| Resistance Level | $49.08 | $0.90 |
| Average True Range (ATR) | 1.03 | 0.07 |
| MACD | 0.25 | 0.08 |
| Stochastic Oscillator | 75.20 | 20.15 |
Price Performance
Historical ComparisonAbout EQH Equitable Holdings Inc.
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.